Cardiology
-
Investigators seek clues to paradox of atrial fibrillation risk
Vanderbilt researchers are seeking genetic clues to explain why risk factors for AF are more prevalent in African-Americans but their incidence of the disease is lower than European-Americans. Read MoreFeb 17, 2012
-
Vanderbilt study finds no heart risk in ADHD medications
Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005. Read MoreNov 2, 2011
-
Lung disorder drug regimen found harmful
Longtime treatment for IPF ineffective and even dangerous. Read MoreOct 31, 2011
-
Vanderbilt doctors to screen patients taking statins for genetic risk factors
Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death. Read MoreOct 28, 2011
-
Study seeks genetic profile of mitral valve regurgitation
The Department of Cardiac Surgery and the Division of Cardiology are collaborating on a study to better understand the genetic profile of mitral valve regurgitation. Read MoreAug 15, 2011
-
New ‘stethoscope’ to monitor critically ill patients
Vanderbilt cardiothoracic anesthesiologists and surgeons are pioneering the use of a tool that many in the cardiac field are calling the “new stethoscope” when it comes to monitoring critically ill patients. Read MoreApr 22, 2011
-
Vanderbilt Heart to participate in CoreValve clinical trial
Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart's aortic valve. Read MoreApr 18, 2011